Product Information
DEXTROAMP-AMPHETAMINE 5 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2640 per EA under NDC 31722015501. Its NADAC has been published 241 times since Jan 12, 2022.
FDA first approved this application on Apr 22, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMINE 5 MG TAB
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfateStrength
1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722015501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA213709FDA Approved
4/22/2021
TE Code
AB
On Market Since
5/10/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has been published 241 times since Jan 12, 2022, and over the history we have for it it has risen 18.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2640 per EA |
|---|---|
| All-time high | $0.3300 (Apr 12, 2023) |
| All-time low | $0.1824 (Jul 17, 2024) |
| 52-week high | $0.2728 |
| 52-week low | $0.2386 |
| Median price | $0.2498 |
| Average price | $0.2510 |
| Largest weekly change | +37.0% (Aug 21, 2024) |
| Weeks tracked | 241 |
| Tracking since | Jan 12, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMINE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMINE 5 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.2640 per EA (NDC 31722015501), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMINE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has risen 18.0%. It has been tracked across 241 weekly CMS publications since Jan 12, 2022.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMINE 5 MG TAB?
Since Jan 12, 2022, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has ranged from a low of $0.1824 (Jul 17, 2024) to a high of $0.3300 (Apr 12, 2023), with a median of $0.2498 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMINE 5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMINE 5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMINE 5 MG TAB?
DEXTROAMP-AMPHETAMINE 5 MG TAB (NDC 31722015501) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.